Takeda Expands Cancer Business With $4.66 Billion Ariad Deal
Takeda Pharmaceutical Co. will expand its footprint in the U.S. oncology market with the $4.66 billion purchase of Ariad Pharmaceuticals ...
Tag: $4.66
© 2023 HealthTopical - Premium WordPress news & magazine theme by HealthTopical.